1.Molecular identification and typing of 182 strains of Streptococcus pneumoniae isolated from children
Yinghui GUO ; Baohua HE ; Yingtong WANG ; Zhaoyi JIA ; Qian WANG ; Guixia LI ; Wenchao ZHANG ; Yinqi SUN ; Suliang CHEN
Chinese Journal of Infection Control 2017;16(4):326-329
Objective To type Streptococcus pneumoniae(S.pneumoniae) isolated from children, and provide scientific basis for the correct selection of S.pneumoniae vaccine.Methods 182 strains of S.pneumoniae were collected from Children's Hospital of Hebei Province in 2014, species of strains were identified by polymerase chain reaction (PCR), types of strains were analyzed with multiplex PCR.Results PCR detection showed that cpsA gene amplification of 182 strains were all positive;multiplex PCR detection revealed that except 8 strains were not typed, the main types of the remaining 174 strains were 19 F (n=68, 37.36%), 19A(n=33, 18.13%), and 6A/6B (n=26,14.28%), the other types were 35B, 14, 6C/6D, 23F, 15B/15C, and so on.Conclusion The main types of 182 strains of S.pneumoniae are 19 F, 19A, and 6A/6B, which provide scientific basis for the correct selection of S.pneumoniae vaccine for this province.
2.The evidence-based practice of bowel preparation by transrectal prostate biopsy
Suliang FU ; Xiaobo ZHOU ; Shina QIAO ; Ying ZHANG ; Fengrong CHEN ; Na ZHOU ; Haili SUN ; Xiaoyan WANG
Chinese Journal of Practical Nursing 2018;34(31):2426-2429
Objective To formulate and standardized the procedure of bowl preparation before transrectal ultrasound-guided prostate biopsy. Methods The standardized transrectal ultrasound-guided prostate biopsy flowchart were formulated based on the best evidences and recommendations. One hundred and forty patients selected with suspected of prostate cancer and scheduled for transrectal ultrasound-guided prostate biopsy was equally assigned to two groups, the control group was given routine hospital practice before biopsy, and the observation group followed the formulated flowchart. Monitoring two groups for complications, time cost for bowl preparation, medical billing and the average day of hospitalization. Results The incidence of complications and the number of hospitalization days between two groups were comparable, the observation group in bowl preparation time was (3.75 ± 0.78) min, the control group in bowl preparation time was (11.88 ± 1.93) min, the difference of two groups showed statistical significance (t=15.643, P<0.01). The observation group in medical bill was¥(81.62±15.62), the control group in medical bill was ¥(427.78 ± 76.87), the difference of two groups showed statistical significance (t=-36.964, P<0.01). Conclusions Application of evidence-based practice to formalize bowl preparation and antibiotic use in transrectal ultrasound-guided prostate biopsy patient can facilitate the clinical nurses to provide homogenized care to prostate biopsy patients as well as improve the efficiency of nursing work.
3.Effect of highly active anti-retroviral therapy on reducing HIV/AIDS related death in Hebei, 1989-2013.
Suliang CHEN ; Email: CHENSULIANG@SINA.COM. ; Lin MA ; Xinli LU ; Yan LI ; Wei WANG ; Yingying WANG ; Cuiying ZHAO ; Yuqi ZHANG ; Hongru ZHAO
Chinese Journal of Epidemiology 2015;36(5):460-464
OBJECTIVETo investigate the effect of highly active anti-retroviral therapy (HAART) on reducing HIV/AIDS related death.
METHODSThe analysis was conducted by using the data of 4,148 HIV/AIDS cases reported in Hebei province from 1989 to 2013. Regular follow-up, CD4 detection, registration of death were carried out for them. Free HAART has been provided to people living with HIV/AIDS who met the treatment requirement since 2003.
RESULTSOf 4,148 HIV/AIDS cases, 12,451.48 person years were observed, 968 cases died due to all registered death causes. The death density was 7.77/100 person years. The death density was 2.87/100 person years for the HIV/AIDS cases receiving HAART, and 16.58/100 for the HIV/AIDS cases receiving no HAART. In 1,894 AIDS cases, a total of 4,774.48 person years were observed from onset to death, 581 cases died due to all registered death causes, and the death density was 121.69/100 person years. The death density was 4.77/100 person years for the cases receiving HAART, and 125.92/100 person years for the cases receiving no HAART. In the cases with CD less than 200/mm3, the death density was 22.9/100 person years for those receiving no HAART and 5.3/100 person years for those receiving HAART. The annual analysis found that the death rate due to all registered death causes declined as the increase of HAART coverage in people living with HIV/AIDS. The expanding of HAART coverage in people infected with HIV can reduce death rate among them.
CONCLUSIONFurther expanding of HAART can effectively reduce the death among people living with HIV/AIDS.
Acquired Immunodeficiency Syndrome ; drug therapy ; mortality ; Antiretroviral Therapy, Highly Active ; Cause of Death ; trends ; China ; epidemiology ; HIV Infections ; drug therapy ; mortality ; Humans ; Treatment Outcome